Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nikan Teb Kimia is an Iranian pharmaceutical company specializing in the importation, registration, and distribution of specialty medicines and medical equipment. Founded in 2011, the company primarily focuses on providing access to critical therapies in oncology, hematology, and neurology for the Iranian healthcare market. It acts as a key partner for international pharmaceutical manufacturers, navigating the local regulatory environment to supply life-saving drugs, including branded generics and supportive care products. The company maintains a strong distribution network reaching hospitals and pharmacies throughout Iran, ensuring the availability of specialized treatments for complex diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nikan Teb Kimia.